Crinetics Pharmaceuticals, Inc.
CRNX US22663K1079
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
104% | -35% | 97% | 44% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Pizzuti Dana SR OFF |
41.81 USD |
5,000 Sold |
209,050 USD |
01/10/2025 | 01/10/2025 |
Struthers Richard Scott CEO |
45.00 USD |
4,000 Sold |
180,000 USD |
26/09/2025 | 26/09/2025 |
Fust Matthew K |
44.75 USD |
16,000 Sold |
716,000 USD |
26/09/2025 | 26/09/2025 |
Pizzuti Dana SR OFF |
32.10 USD |
5,000 Sold |
160,500 USD |
02/09/2025 | 02/09/2025 |
Pizzuti Dana SR OFF |
32.10 USD |
5,000 Sold |
160,500 USD |
02/09/2025 | 02/09/2025 |
Pizzuti Dana SR OFF |
30.43 USD |
30,000 Sold |
912,900 USD |
22/08/2025 | 22/08/2025 |
Pizzuti Dana SR OFF |
29.18 USD |
6,492 Sold |
189,437 USD |
20/08/2025 | 20/08/2025 |
Betz Stephen F. CSO |
32.23 USD |
97,483 Sold |
3,141,877 USD |
12/06/2025 | 12/06/2025 |
Betz Stephen F. CSO |
34.17 USD |
5,479 Sold |
187,217 USD |
19/03/2025 | 19/03/2025 |
Pizzuti Dana SR OFF |
34.83 USD |
127 Sold |
4,423 USD |
19/03/2025 | 19/03/2025 |